MORTALITY ANALYSIS OF THE PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS
Background. Alcohol is considered to be the main risk factor for adverse event deaths around the world. In Ukraine, mortality due to alcoholic liver disease (ALD) has taken the second place in the structure of death causes from diseases of the digestive system.
Objective. The aim of the research was to study the peculiarities of the causes of death in the patients with alcoholic liver disease at the stage of liver cirrhosis (LC) based on the analysis of protocols of pathoanatomical research.
Methods. The analysis of 149 protocols of the pathoanatomical study of the patients, who died from alcoholic LC, has been carried out at the premises of the Pathoanatomical Department of the Ivano-Frankivsk Regional Clinical Hospital in 2006-2018.
Results. Most people were young and middle aged. Fatal cases were caused by decompensation of the LC with the development of hepatic, hepatic-renal, cardio-pulmonary insufficiency, pancreatic necrosis, gastrointestinal bleeding (GIB), sepsis, hepatocellular carcinoma (HCC). In 37.6 % of the patients the concomitant illness was coronary heart disease (CHD), 10.7 % of the people had hypertension. In 6 % of the patients, ischemic stroke of the brain was diagnosed. In most people atherosclerotic vascular changes were revealed.
Conclusions. Excessive consumption of alcohol and, consequently, the development of LC, can be considered as an adverse factor in the reducing social standard of living. In the majority of people, who died from the decompensation of alcoholic LC, atherosclerotic vascular lesions have been detected. This indicates a significant prevalence of lipid metabolism disturbance in the people with alcoholic LC.
Melnyk PS, Slabkyi HO, Dziuba OM, Chepelevska LA, Kudrenko MV. Annual report on the health status of the population, the sanitary and epidemiological situation and the results of the Ukrainian health care system, 2016. Kyiv: Ministry of health of Ukraine, GA “Ukrainian Institute of Strategic Studies Ministry of Health of Ukraine”. 2017;516 [In Ukrainian]. Available at: https://dspace.uzhnu.edu.ua/jspui/handle/lib/20687
Sherstiuk NS, Sokolov AV. Health of Ukraine’s population and its impact on the demographic situation. Economics and Society. 2016;5:316-19 [In Ukrainian]. Available at: http://www.economyandsociety.in.ua/journal/5_ukr/57.pdf
Parkheta LV. Medical demographic indicators and their impact on the development of voluntary health insurance in Ukraine. Effective economy. 2018;1 [In Ukrainian]. Available at: http://www.economy.nayka.com.ua/?op=1&z=6084
Chepelevska LA, Dziuba OM, Kruchanytsia VV. Regional peculiarities of mortality of the population of Ukraine from fibrosis and cirrhosis of the liver and alcoholic liver disease. Ukraine. The health of the nation. 2016;4/1(41):218-23 [In Ukrainian]. Available at: http://www.irbis-nbuv.gov.ua/cgi-bin/irbis_nbuv/cgiirbis_64.exe?C21COM=2&I21DBN=UJRN&P21DBN=UJRN&IMAGE_FILE_DOWNLOAD=1&Image_file_name=PDF/Uzn_2016_4(1)__39.pdf
Ruiz-Margáin A, Macías-Rodríguez RU, Ríos-Torres SL, Román-Calleja BM, Méndez-Guerrero O, Rodríguez-Córdova P, et al. Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis. Rev Gastroenterol Mex. 2018;83:9. doi: 10.1016/j.rgmxen.2017.02.005
Ali Mokdad A, Lopez АD, Shahraz S, Lozano R, Ali Mokdad H, Stanaway J et. al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Medicine 2014;12:145. doi: 10.1186/s12916-014-0145-y
Nilsson E, Anderson H, Sargenti K, Lindgren S, Prytz H. Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden: a 10-year populationbased study. Aliment Pharmacol Ther 2016 Jun; 43(12):1330-9. doi: 10.1111/apt.13635
Osodlo HV. Epidemiological and therapeutic aspects of chronic diffuse liver disease in military personnel. Gastroenterology. 2013;4(50):50-6 [In Ukrainian]. Available at: http://www.mif-ua.com/archive/article/37743
Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, Roerecke M. Alcohol as a risk factor for liver cirrhosis: A systematic review and meta-analysis. Drug and Alcohol Review. 2010 Jul; 29(4):437-45. doi: 10.1111/j.1465-3362.2009.00153.x
Schiavo L, Busetto L, Cesaretti M, Zelber-Sagi Sh, Deutsch L, Iannelli A. Nutritional issues in patients with obesity and cirrhosis. World J Gastroenterol. 2018;24(30):3330-3346. doi: 10.3748/wjg.v24.i30.3330
Chepelevska LA, Krapivina AA. Features of the mortality rate of the population of Ukraine from individual diseases of the digestive system. Ukraine. The health of the nation. 2013; 1 (25): 54-8 [In Ukrainian]. Available at: http://www.irbis-nbuv.gov.ua/cgi-bin/irbis_nbuv/cgiirbis_64.exe?21COM=2&I21DBN=UJRN&P21DBN=UJRN&IMAGE_FILE_DOWNLOAD=1&Image_file_name=PDF/Uzn_2013_1_10.pdf
Allen A. M., Kim W. R. Epidemiology and healthcare burden of acute-on-chronic liver failure. Sem Liv Dis 2016 May;36(2):123-6. doi: 10.1055/s-0036-1583201
Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 2016; 51:629-650. doi: 10.1007/s00535-016-1216-y
Chen H, Zhang Y, Li S, Li N , Chen Y, Zhang B. Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma. Cancer Manag Res. 2018;10:1947-1958. doi: 10.2147/CMAR.S167036
Fialla AD, Israelsen M, Hamberg O, Krag A, Gluud LL. Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis. Liver Int. 2015; 35:2072-2078. doi: 10.1111/liv.12798
Garbuzenko D, Arefyev N, Kazachkov E. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives. World J Gastroenterol. 2018;24(33):3738-3748. doi: 10.3748/wjg.v24.i33.3738
Authors who sent their manuscript to International Journal of Medicine and Medical Research agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License CC-BY-NC that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).